Skip to main content
MRK
NYSE Life Sciences

默克2026年销售预测为203-211亿欧元受到Januvia降价、仿制药的影响

feedReported by Wiseek News
Sentiment info
Negative
Importance info
8
Price
$115.78
Mkt Cap
$286.254B
52W Low
$73.31
52W High
$125.14
Market data snapshot near publication time

summarizeSummary

默克公司已发布2026年净销售预测为203-211亿欧元，EBITDA为55-60亿欧元。这一预测反映了重大不利因素，包括估计在2026年因通货膨胀减少法案（IRA）而导致Januvia降价的收入影响约为15亿美元，以及Mavenclad的仿制药竞争和不利的外汇影响。该具体的财务预测在公司最近的10-K报告之后提供了具体细节，10-K报告曾广泛警告由于IRA价格设定和专利到期而导致未来的收入下降。对Januvia和其他因素的详细影响提供了新的、重要信息，以便投资者评估公司近期收入轨迹。交易者将密切关注默克公司如何减轻这些收入压力的进一步澄清，特别是通过新的产品增长。

在该公告发布时，MRK的交易价格为$115.78，交易所为NYSE，所属行业为Life Sciences，市值约为$2862.5亿。 52周交易区间为$73.31至$125.14。 这则新闻被评估为消极市场情绪，重要性评分为8/10。 来源：Wiseek News。

show_chartPrice Chart

Share this article

Copied!

feed MRK - Latest Insights

MRK
Apr 24, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Merck Clears Key Antitrust Hurdle for Terns Pharmaceuticals Acquisition
Sentiment: Positive
View Wiseek Article
MRK
Apr 21, 2026, 11:50 AM EDT
Source: Reuters
Importance Score:
8
US FDA Approves Merck's New Combination HIV Treatment
Sentiment: Positive
View Wiseek Article
MRK
Apr 21, 2026, 6:51 AM EDT
Source: Reuters
Importance Score:
8
Merck-Eisai Cancer Therapy Fails Late-Stage Study Goals
Sentiment: Negative
View Wiseek Article
MRK
Apr 20, 2026, 7:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
FDA Grants Priority Review to Merck, Pfizer Bladder Cancer Drug Combo
Sentiment: Positive
View Wiseek Article
MRK
Apr 13, 2026, 4:06 PM EDT
Source: Wiseek News
Importance Score:
8
Merck Actively Pursues Acquisitions to Bolster Pipeline Ahead of Keytruda Patent Expiration
Sentiment: Positive
View Wiseek Article
MRK
Apr 08, 2026, 4:25 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Merck Projects Over $70B Pipeline Opportunity, Details Executive Changes and Annual Meeting Proposals
Sentiment: Positive
View Wiseek Article
MRK
Mar 30, 2026, 4:04 PM EDT
Source: Wiseek News
Importance Score:
9
Merck's Oral PCSK9 Inhibitor Enlicitide Cuts LDL-C 64.6% in Phase 3, Outperforming Competitors
Sentiment: Positive
View Wiseek Article
MRK
Mar 30, 2026, 11:48 AM EDT
Source: Reuters
Importance Score:
9
Merck's Oral PCSK9 Inhibitor Enlicitide Decanoate Slashes LDL-C by 64.6%, Earns FDA Priority Voucher
Sentiment: Positive
View Wiseek Article
MRK
Mar 29, 2026, 11:49 AM EDT
Source: Reuters
Importance Score:
8
Merck's Winrevair Hits Phase 2 Endpoint, Advancing to Registrational Phase 3 for Pulmonary Hypertension
Sentiment: Positive
View Wiseek Article
MRK
Mar 25, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Merck Acquires Terns Pharma, Bolstering Hematology Pipeline with Novel CML Candidate TERN-701
Sentiment: Positive
View Wiseek Article